• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Medical Histology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2024)
Issue Issue 1
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Altaib, Z., Khaled, D., Mohamed, M. (2024). Alfacalcidol as A Protective Agent Against Gastrocnemius Muscle Damage after Atorvastatin Intake: A Histological and Biochemical Study. Journal of Medical Histology, 8(1), 13-31. doi: 10.21608/jmh.2024.329545.1133
Zainab Altaib; Doaa Khaled; Mohamed Mohamed. "Alfacalcidol as A Protective Agent Against Gastrocnemius Muscle Damage after Atorvastatin Intake: A Histological and Biochemical Study". Journal of Medical Histology, 8, 1, 2024, 13-31. doi: 10.21608/jmh.2024.329545.1133
Altaib, Z., Khaled, D., Mohamed, M. (2024). 'Alfacalcidol as A Protective Agent Against Gastrocnemius Muscle Damage after Atorvastatin Intake: A Histological and Biochemical Study', Journal of Medical Histology, 8(1), pp. 13-31. doi: 10.21608/jmh.2024.329545.1133
Altaib, Z., Khaled, D., Mohamed, M. Alfacalcidol as A Protective Agent Against Gastrocnemius Muscle Damage after Atorvastatin Intake: A Histological and Biochemical Study. Journal of Medical Histology, 2024; 8(1): 13-31. doi: 10.21608/jmh.2024.329545.1133

Alfacalcidol as A Protective Agent Against Gastrocnemius Muscle Damage after Atorvastatin Intake: A Histological and Biochemical Study

Article 13, Volume 8, Issue 1, June 2024, Page 13-31  XML PDF (4.68 MB)
Document Type: Original Article
DOI: 10.21608/jmh.2024.329545.1133
View on SCiNiTO View on SCiNiTO
Authors
Zainab Altaib1; Doaa Khaled email orcid 2; Mohamed Mohamed1
1Department of Histology and Cytology, Faculty of Medicine, Helwan University, Cairo, Egypt
2Department of Histology and Cytology, Faculty of Medicine, Helwan University, & MUST University, Cairo, Egypt
Abstract
Background and Objective: Atorvastatin (Ator) is widely used to lower blood cholesterol but often causes muscle-related side
effects. Alfacalcidol (Alf), a vitamin D analog, has shown positive effects on muscle health. This study aimed to elucidate the
possible protective role of Alf on gastrocnemius muscle damage after Ator intake in male albino rats.
Materials and Methods: Thirty-six adult male albino rats were randomly divided into three groups: Group I (Control; n = 12),
Group II (Ator-treated; n = 12), and Group III (Ator and Alf-treated; n = 12). Group II received Ator (10 mg/kg/day) in 0.5 ml
distilled water containing 2 mg Ator. Group III received Alf (1 μg/kg/day) concomitantly with Ator, prepared by crushing and
dissolving tablets in 0.5 ml distilled water. All drugs were administered orally for 4 weeks. Twenty-four hours after the last dose,
rats were sacrificed under anesthesia by intraperitoneal injection of phenobarbital (80 mg/kg). A biochemical study for creatine
phosphokinase (CPK) was performed. Muscle specimens were dissected and examined using light microscopy (Hematoxylin
and Eosin, Masson’s trichrome, and PAS stains) and electron microscopy. Morphometric and statistical analyses were conducted.
Results: Group II showed histological changes indicating myopathy and degenerative changes, which regressed in Group III.
The mean CPK values significantly increased in Group II compared to the control and Group III.
Conclusions: Alfacalcidol demonstrated a definitive protective effect against Ator-induced skeletal muscle damage, confirmed
through biochemical and histological analyses. Alf can be recommended for hypercholesterolemic patients on Statins, particularly
those at risk of vitamin D deficiency.
Keywords
Alfacalcidol; muscle damage; special stains; statin; ultrastructure
Statistics
Article View: 131
PDF Download: 152
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.